Sifaysan

Soo saaraha Covid-19 Tijaabada Degdega ah ee Kelida Adeegga - 2019-nCOV IgGIgM Qalabka Tijaabada Degdega ah (hal adeeg) - Realy

Sharaxaad Gaaban:



Faahfaahinta Alaabta

FAQ

Soo koobida Badbaadada iyo Waxqabadka

Tags Product

Waxaan nafteena u huri doonnaa inaan siino iibsadayaashayada sharafta leh iyagoo isticmaalaya adeegyada ugu xamaasadda badanQalabka Tijaabada Coronavirus ee Dhiiga,Tijaabooyinka degdega ah ee Coronavirus,Qalabka Tijaabada ee Coronavirus 2019, Tayada ugu sareysa, shirkad waqtigeeda ku habboon iyo kharash gardarro ah, dhammaantood waxay nagu guulaystaan ​​caan ka sarreeya garoonka xxx inkasta oo tartan caalami ah uu ka jiro.
Soo saaraha Covid-19 Tijaabada Degdega ah ee Kelida Adeegga - 2019-nCOV IgGIgM Qalabka Tijaabada Degdega ah (hal adeeg) - RealyDetail:

Dareenka iyo Gaarka: Aaladda 2019-nCOV/COVID-19 IgG/IgM Qalabka Tijaabada Degdegga ah ayaa la barbardhigay RT-Tijaabada PCR ee hormuudka ka ah iyada oo la adeegsanayo muunado caafimaad. Natiijooyinku waxay muujinayaan in 2019-nCoV/COVID-19 IgG/IgM Qalabka Tijaabada Degdegga ah uu leeyahay dareen sare iyo gaar ahaaneed.

Imtixaanka IgG:

HabkaRT-PCRWadarta Natiijooyinka
2019-nCOV IgG/IgM Qalabka Tijaabada Degdega ahNatiijooyinkaWanagsanxun
Wanagsan2332235
xun35287322
Wadarta Natiijooyinka268289557

Dareenka Qaraabada:233/268=86.94%(95%CI*:82.35%-90.49%)

Gaar ahaan Qaraabada:287/289=99.31% (95%CI*:97.52%-99.92%)

Sax:520/557=93.36% (95%CI*: 90.96%-95.16%)

* Kalsoonida Dhexdeeda

Imtixaanka IgM

HabkaRT-PCRWadarta Natiijooyinka
2019-nCOV IgG/IgM Qalabka Tijaabada Degdega ahNatiijooyinkaWanagsanxun
Wanagsan2237230
xun45282327
Wadarta Natiijooyinka268289557

Dareenka Qaraabada:223/268=83.21% (95%CI*:78.19%-87.48%)

Gaar ahaan Qaraabada:282/289=97.58% (95%CI*: 95.07%-99.02%)

Saxnimada: 505/557=90.66% (95%CI*: 87.94%-92.95%)

* Kalsoonida Dhexdeeda

The 2019-nCOV/COVID-19 IgG/IgM Qalabka Tijaabada Degdega ah waa immunoassay chromatographic degdeg ah oo loogu talagalay ogaanshaha tayada ee IgG&IgM antibody of Coronavirus Disease 2019 ee dhiiga bini'aadamka oo dhan, serum, ama balaasmaha sida gargaar lagu ogaanayo caabuqyada COVID-19.

Isticmaalka la damacsan yahay: 2019-nCOV/COVID-19 IgG/IgM Qalabka Tijaabada Degdegga ah waa immunoassay chromatographic degdeg ah oo loogu talagalay ogaanshaha tayada ee IgG&IgM antibody of Coronavirus Disease 2019 ee dhiiga bini'aadamka oo dhan, serum, ama balaasmaha si gargaar loogu helo ogaanshaha caabuqyada COVID-19.

KOOBAN: COVID-19 waa cudur faafa oo neef-mareenka oo degdeg ah. Dadku guud ahaan waa u nugul yihiin. Hadda, bukaannada uu ku dhacay cudurka 'coronavirus' cusub ayaa ah isha ugu weyn ee caabuqa; Dadka cudurka asymptomatic-ka ah sidoo kale waxay noqon karaan il faafa. Iyada oo ku saleysan baaritaanka cudurrada faafa ee hadda, muddada soo-baxa waa 1 ilaa 14 maalmood, badiyaa 3 ilaa 7 maalmood. Calaamadaha ugu waaweyn waxaa ka mid ah qandho, daal iyo qufac qalalan. Sanka oo ciriiri ah, diif, cune xanuun, myalgia iyo shuban ayaa laga helaa dhowr xaaladood.

Tilmaamaha ISTICMAALKA: Oggolow qalabka tijaabada, muunada, kaydinta, iyo/ama kontaroolada inay gaadhaan heerkulka qolka (15-30°C) kahor tijaabada. 1. Keen kiishka heerkulka qolka ka hor inta aanad furin. Ka saar aaladda tijaabada shandad xidhan oo isticmaal sida ugu dhakhsaha badan. 2. Dhig qalabka tijaabada dusha nadiif ah oo siman. ? Noocyada Serum ama Plasma: Isticmaalka pipette la tuuri karo oo ah 10μL, soo jiid muunada ilaa khadka Buuxinta, oo ku wareeji 10μL serum/plasma muunada si fiican ee aaladda tijaabada, ka dibna ku dar 2 dhibcood oo kayd ah oo bilow saacada. ? Dhiiga Dhan (Venipuncture/Fingerstick) Noocyada: Isticmaalka pipette la tuuri karo ee 10μL ah, oo ku wareeji 1 dhibcood oo dhiig ah (qiyaastii 20μL) muunada si fiican ee aaladda tijaabada,kadib ku dar 2 dhibcood oo bakhaar ah oo bilow saacada. Fiiro gaar ah: Muunadaha waxa kale oo lagu marsiin karaa micropipette. 3. Sug inta laynka midabka leh uu soo baxayo.Akhri natiijada 10 daqiiqo. Ha fasirin natiijada 15 daqiiqo ka dib.

sdv

Mabda'a: Qalabkani waxa uu isticmaalaa immunochromatography.Kaarka tijaabada waxa uu ka kooban yahay:1) kolloidal dahab ah-lagu calaamadeeyay recombinant novel coronavirus antigen iyo ilaalinta tayada ilaalinta caalamadaha dahabka;2) laba xariiq oo ogaanshaha (IgG iyo IgM khadadka) iyo hal tayada xakamaynta (C line) ee xuubka nitrocellulose. Khadka M waxa lagu dhaqaajiyaa iyada oo leh monoclonal anti - antibody IgM bini aadamka si loo ogaado cudurka cusub ee coronavirus IgM antibody; khadka IgG waxa lagu dhaqaajiyay reagent si loo ogaado cudurka cusub ee coronavirus IgG antibody; iyo khadka C waa mid aan dhaqdhaqaaq lahayn oo leh antibody-ka ilaalinta tayada. Marka qadar ku habboon muunadda tijaabada lagu daro daloolka muunadda ee kaadhka tijaabada, muunadda ayaa hore ugu sii socon doonta kaadhka tijaabada iyada oo la raacayo ficilka xididka Dhismaha difaaca jirka waxa qabsan doona ka hortagga - bini'aadamka IgM ka-hortagga xuubka si uu u sameeyo khad guduudan Haddii shaybaarku ka kooban yahay antibody IgG, antibody-gu wuxuu ku xidhmi doonaa dahabka kolloidalka ah ee ku suntan coronavirus antigen, iyo isku dhafka difaaca jirka waxaa qaban doona reagent immobilized on xuubka si uu u sameeyo guduud - guduudan IgG line, taasoo muujinaysa in novel coronavirus IgG antibody waa togan. Haddii baaritaanka IgG iyo IgM aysan midab lahayn, natiijo xun ayaa soo baxaysa. Kaarka tijaabada sidoo kale wuxuu ka kooban yahay xariiqda xakamaynta tayada C. Khadka xakamaynta tayada fuchsia C waa inuu soo muuqdaa iyada oo aan loo eegin haddii xariiqda tijaabada ahi u muuqato. Haddii xariiqda xakamaynta tayada C uusan soo bixin, natiijadu waa mid aan sax ahayn, muunaddana waxay u baahan tahay in mar kale lagu tijaabiyo kaadh kale oo tijaabo ah.


Sawirro tafatiran ee alaabta:

Manufacturer of Covid-19 Rapid Test For Single Serving - 2019-nCOV IgGIgM Rapid Test Device(single serving) – Realy detail pictures

Manufacturer of Covid-19 Rapid Test For Single Serving - 2019-nCOV IgGIgM Rapid Test Device(single serving) – Realy detail pictures

Manufacturer of Covid-19 Rapid Test For Single Serving - 2019-nCOV IgGIgM Rapid Test Device(single serving) – Realy detail pictures

Manufacturer of Covid-19 Rapid Test For Single Serving - 2019-nCOV IgGIgM Rapid Test Device(single serving) – Realy detail pictures

Manufacturer of Covid-19 Rapid Test For Single Serving - 2019-nCOV IgGIgM Rapid Test Device(single serving) – Realy detail pictures

Manufacturer of Covid-19 Rapid Test For Single Serving - 2019-nCOV IgGIgM Rapid Test Device(single serving) – Realy detail pictures

Manufacturer of Covid-19 Rapid Test For Single Serving - 2019-nCOV IgGIgM Rapid Test Device(single serving) – Realy detail pictures

Manufacturer of Covid-19 Rapid Test For Single Serving - 2019-nCOV IgGIgM Rapid Test Device(single serving) – Realy detail pictures


Hagaha Alaabta La Xiriira:

Si aad si joogto ah u kordhiso barnaamijka maamulka iyada oo laga duulayo qaanuunka "si daacad ah, diinta wanaagsan iyo tayada sare waa saldhigga horumarinta ganacsiga", waxaanu si weyn u nuugaynaa nuxurka alaabooyinka ku xiran caalamka, waxaanan si joogto ah u soo saareynaa alaabo cusub si aan u qancino baaqyada dukaamada ee Soosaaraha Covid-19 Tijaabada Degdega ah ee Kelida Adeegga - 2019-nCOV IgGIgM Qalabka Tijaabada Degdegga ah (hal adeeg) - Realy, Alaabta ayaa siin doonta adduunka oo dhan, sida: Kazakhstan, South Africa, Bahamas, Waxaan ku guuleysanay sumcad wanaagsan macaamiisha dibadda iyo gudaha. U hoggaansanaanta mabda'a maamulka ee "Credit oriented, macmiilka marka hore, hufnaan sare iyo adeegyada bislaaday", waxaan si diiran u soo dhawaynaynaa saaxiibo ka socda dhammaan qaybaha bulshada si ay nagala shaqeeyaan.


Halkan ku qor fariintaada oo noo soo dir